Selected article for: "antiviral drug and novel coronavirus"

Author: Duc Duy Nguyen; Kaifu Gao; Jiahui Chen; Rui Wang; Guo-Wei Wei
Title: Potentially highly potent drugs for 2019-nCoV
  • Document date: 2020_2_13
  • ID: g5wpa2ee_1
    Snippet: The 2019 novel coronavirus (2019-nCoV) caused the pneumonia outbreak in Wuhan, China, in late December 2019 and has rapidly spread around the world. By Feb 5, 2020, more than 24000 individuals were infected and more than 490 fatalities had been reported. The World Health Organization (WHO) has declared this novel coronavirus outbreak a global health emergency. Currently, there is no specific antiviral drug for this epidemic. Considering the sever.....
    Document: The 2019 novel coronavirus (2019-nCoV) caused the pneumonia outbreak in Wuhan, China, in late December 2019 and has rapidly spread around the world. By Feb 5, 2020, more than 24000 individuals were infected and more than 490 fatalities had been reported. The World Health Organization (WHO) has declared this novel coronavirus outbreak a global health emergency. Currently, there is no specific antiviral drug for this epidemic. Considering the severity of this widespread dissemination and health threats, panic patients misled by media flocked to the pharmacies for Chinese Medicine herbs which were reported to "inhibit" the 2019-nCoV, despite no clinical evidence supporting the claim. Many researchers are engaged in developing anti-2019-nCoV drug s [1, 2] . However, new drug discovery and development is a long, costly and rigorous scientific process. A more effective approach is to search for anti-2019-nCoV therapies from the existing FDA-approved drug database.

    Search related documents:
    Co phrase search for related documents